Clinical Trial Result Information

Protocol number
ML18242

Title of Study
Open-label, randomised and multi-center study evaluating the efficacy and safety of an optimised background antiretroviral regimen (OB) compared to OB associated with enfuvirtide in previously treated HIV-1 infected patients in virological success after a 28-week induction treatment with enfuvirtide plus OB

Sponsor
Roche SAS

Company division
Pharmaceutical

Product name
Fuzeon

Generic name
enfuvirtide

Therapeutic area
HIV infection

Clinical study summary
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Phase of development
III

Date of report
To be Published

Click here for the protocol registry listing of this trial.